OLSON, RICHARD E.,CACACE, ANGELA M.,HAGEDORN, PETER,HOG, ANJA MOLHART,JENSEN, MARIANNE LERBECH,NIELSEN, NIELS FISKER,LI, DONG,BROWN, JEFFREY M.,MERCER, STEPHEN E.
申请号：
CA2975525
公开号：
CA2975525A1
申请日:
2016.02.04
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
The present invention relates to oligomer compounds (oligomers), which target Tau mRNA in a cell, leading to reduced expression of Tau protein. Reduction of Tau protein expression is beneficial for the treatment of certain medical disorders, e.g., a neurological disorder.
